Cite
HARVARD Citation
Wu, J. et al. (2016). Comparison of detection methods and follow-up study on the tyrosine kinase inhibitors therapy in non-small cell lung cancer patients with ROS1 fusion rearrangement. BMC cancer. 16 (1), pp. 1-12. [Online].